Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Nuche

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
European Journal of Heart Failure|November 20, 2022
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trialAna García-Álvarez, Isabel Blanco, Inés García-Lunar, et al.
The Canadian Journal of Cardiology|July 7, 2025
Pacemaker Risk Stratification in Patients With Pre-existing Right Bundle Branch Block Undergoing Transcatheter Aortic Valve ReplacementAlejandro Travieso, Jorge Nuche, Gabriela Tirado-Conte, et al.
Revista Espanola De Cardiologia (English Ed.)|November 24, 2023
Incidence, predictors, and prognostic significance of impaired functional status early after transcatheter aortic valve replacementJorge Nuche, Julien Ternacle, Marisa Avvedimento, et al.
Heart Rhythm|December 18, 2024
Prospective validation of a prespecified algorithm for the management of conduction disturbances after transcatheter aortic valve replacement: The PROMOTE studyJosep Rodés-Cabau, Luis Nombela-Franco, Guillem Muntané-Carol, et al.
Circulation. Cardiovascular Interventions|February 5, 2026
Cardiac Structural Complications Following TAVRSilvia Mas-Peiro, Guillem Muntané-Carol, Julien Ternacle, et al.
Revista Espanola De Cardiologia (English Ed.)|May 19, 2024
Clinical impact of complex percutaneous coronary intervention in the pre-TAVR workupMarisa Avvedimento, Francisco Campelo-Parada, Luis Nombela-Franco, et al.
Theranostics|June 29, 2026
NOD1 is a key mediator of atrial myopathy in heart failureMarta Gil-Fernández, Almudena Val-Blasco, Andrea Bueno-Sen, et al.
The Canadian Journal of Cardiology|December 22, 2024
Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients With New York Heart Association Functional Class III or IVJorge Nuche, Jules Mesnier, Julien Ternacle, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 26, 2026
Prognostic value of early haemodynamic valve deterioration after TAVIAntonin Trimaille, Olivier Morel, Alberto Alperi, et al.
Heart Rhythm|July 1, 2026
Conduction system pacing in TAVR patients requiring permanent pacemaker implantationQuentin Fischer, Jorge Nuche, Atef Badreddine, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
European Journal of Heart Failure|November 20, 2022
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trialAna García-Álvarez, Isabel Blanco, Inés García-Lunar, et al.
The Canadian Journal of Cardiology|July 7, 2025
Pacemaker Risk Stratification in Patients With Pre-existing Right Bundle Branch Block Undergoing Transcatheter Aortic Valve ReplacementAlejandro Travieso, Jorge Nuche, Gabriela Tirado-Conte, et al.
Revista Espanola De Cardiologia (English Ed.)|November 24, 2023
Incidence, predictors, and prognostic significance of impaired functional status early after transcatheter aortic valve replacementJorge Nuche, Julien Ternacle, Marisa Avvedimento, et al.
Heart Rhythm|December 18, 2024
Prospective validation of a prespecified algorithm for the management of conduction disturbances after transcatheter aortic valve replacement: The PROMOTE studyJosep Rodés-Cabau, Luis Nombela-Franco, Guillem Muntané-Carol, et al.
Circulation. Cardiovascular Interventions|February 5, 2026
Cardiac Structural Complications Following TAVRSilvia Mas-Peiro, Guillem Muntané-Carol, Julien Ternacle, et al.
Revista Espanola De Cardiologia (English Ed.)|May 19, 2024
Clinical impact of complex percutaneous coronary intervention in the pre-TAVR workupMarisa Avvedimento, Francisco Campelo-Parada, Luis Nombela-Franco, et al.
Theranostics|June 29, 2026
NOD1 is a key mediator of atrial myopathy in heart failureMarta Gil-Fernández, Almudena Val-Blasco, Andrea Bueno-Sen, et al.
The Canadian Journal of Cardiology|December 22, 2024
Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients With New York Heart Association Functional Class III or IVJorge Nuche, Jules Mesnier, Julien Ternacle, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 26, 2026
Prognostic value of early haemodynamic valve deterioration after TAVIAntonin Trimaille, Olivier Morel, Alberto Alperi, et al.
Heart Rhythm|July 1, 2026
Conduction system pacing in TAVR patients requiring permanent pacemaker implantationQuentin Fischer, Jorge Nuche, Atef Badreddine, et al.
Pageof 8